Most Recent
Flight Centre faces court action by workers for alleged systemic underpayment
Flight Centre has been hit with legal action on behalf of employees accusing the travel giant of short-changing its workers through commission-based payments.
King & Wood Mallesons lands two dispute resolution hotshots
International law firm King & Wood Mallesons has nabbed two leading litigators to bolster the ranks of its dispute resolution practice, the firm said Friday.
Nine defamed British tourist with ‘coward punch’ broadcast, court finds
Nine Network has been ordered to pay a British tourist $100,000 in a defamation suit over a news broadcast that aired following his acquittal on assault charges related to a brawl with rugby player that used the term "coward punch" to describe the dust-up.
Red Bull wins cancellation of Bullsone’s trade mark after auto parts company a no-show
Energy drink giant Red Bull has won judgment against South Korea's Bullsone in a battle over the auto parts company's Australian trade mark for a leaping red and black bull. 
Forex trader Berndale Capital placed into receivership
The Australian Securities and Investments Commission has won its bid for a court order placing Melbourne-based forex trader Berndale Capital into receivership for allegedly failing to safeguard client money.
PE company sues to enforce $161M arbitration award against Spain
Two units of private equity company Antin Infrastructure Partners have taken their legal battle with Spain to Australian court, filing a lawsuit to enforce a $161 million arbitration award related to investments the companies made in two solar plants in southern Spain.
Sanofi drops injector pen patent case against Alphapharm
After losing its fight for a temporary injunction, Sanofi-Aventis has dropped its patent lawsuit against Alphapharm over the generic drug maker's plans to market a competing insulin injector pen in Australia.
Generic drug maker Juno can’t withdraw admission ahead of trial over Velcade patent
A judge has refused an application by generic drug maker Juno Pharmacueticals to withdraw an admission in a battle with Millennium Pharmaceuticals over its cheap version of breakthrough cancer drug Velcade, denying Juno a potential defence to allegations of patent infringement.
Class action seeks emails, board notes from Woolworths execs
A shareholder class action against Woolworths related to its downward revision of a 2015 profit guidance is seeking emails and other documents from a slew of current and former company executives, including the grocery chain's former Chairman and CEO, who departed in the wake of disappointing financial results.
After drawing scrutiny from judge, toxic foam class action funding structure revealed
The sought-after commission at the centre of an unsuccessful common fund application in a class action over the use of toxic foam at a RAAF base near Katherine, NT has been revealed as 15% of any gross recovery in the case plus up to three and a half times the funder's costs.